Image 01
Chemical structure of cimetidine hydrochloride, showing its molecular arrangement with a labeled HCl component.*
Cimetidine Hydrochloride Oral Solution
Product Images NDC 50383-050
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cimetidine Hydrochloride Oral Solution (NDC 50383-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn Operating Company Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
This table presents data on the stimulant, stimulant dose, Cimetidine dose, and percentage of inhibition at specific time points. It compares Betazole, Pentagastrin, Caffeine, and Insulin, showing their dosages and corresponding % inhibition values at noted hours after administration.*
Image 03
A table titled 'Duodenal Ulcer Healing Rates With Various Oral Cimetidine Dosage Regimens' showing healing percentages at weeks 4, 6, and 8 for different daily dosages and administration frequencies (300 mg q.i.d., 400 mg b.i.d., 800 mg h.s., 1600 mg h.s.). Data represents averages from controlled clinical trials.*
Image 04
A text panel presenting results from a clinical study comparing healing rates between Cimetidine and placebo over weeks 2 and 6. It shows the number and percentage of healed cases for each group and notes statistical significance with p-values. The context is an 800 mg oral regimen evaluated endoscopically in a U.S. multicenter study.*
Image 05
A data table comparing the effects of Cimetidine at two dosages (800 mg b.i.d. and 400 mg q.i.d.) versus placebo across two clinical trials. The table presents percentages of outcomes at weeks 6 and 12, along with p-values for statistical comparison of 800 mg b.i.d. versus placebo.*
Image 06
Label for Cimetidine Hydrochloride Oral Solution 300 mg per 5 mL by Akorn Operating Company LLC. The label indicates an 8 fl oz (237 mL) bottle, includes usage instructions and storage information, and shows the NDC 50383-050-08. It cautions to use safety closures and store at controlled room temperature.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
